Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Exhibitors at UBIFRANCE French Pavilion
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ONLYLYON ADERLY<br />
Place de la Bourse<br />
69002 LYON - FRANCE<br />
Phone: +33 4 72 40 81 98<br />
Email: delumley@aderly.com<br />
Web site: www.aderly.com<br />
Contact: Thierry de LUMLEY<br />
ADERLY’s key strength is to provide a customized business development service. This<br />
includes one-to-one meetings with potential customers, R&D partners and key opinion<br />
leaders, as well as lawyers, accountants, public investors, venture capitalists and<br />
business angels. In Lyon, join leaders such as Genzyme, Biomérieux, Merial, Becton<br />
Dickinson, Mylan, Covidien, Sanofi-Pasteur, Merck Serono, Integra Life Sciences,<br />
Baxter, Abbott Pharma and Olympus Biotechnology, along with other companies who<br />
have been assisted by ADERLY in the boosting of their European business: Singulex,<br />
Oncotherapy Sciences, Prediction Sciences, CellSeed and more.<br />
ONLYLYON<br />
GREATER LYON<br />
20 rue du lac - BP 3103<br />
69399 LYON Cedex 03 - FRANCE<br />
Phone: +33 4 78 63 42 31<br />
Fax: +33 4 26 99 38 74<br />
Email: clab<strong>at</strong>@grandlyon.org<br />
Web site:<br />
www.entreprendre @grandlyon.org<br />
Contact: Clémence LABAT<br />
Through its partnership-based approach, Gre<strong>at</strong>er Lyon <strong>at</strong>tracts year after year more<br />
investors and intern<strong>at</strong>ional business leaders. The skills of the institutional partners<br />
of the Life Sciences are leveraged to <strong>at</strong>tract talent, support innov<strong>at</strong>ion and help<br />
companies start up and develop.<br />
Gre<strong>at</strong>er Lyon financially supports the actions of the Lyonbiopôle competitive cluster<br />
and of the Cancer Center CLARA research cluster, as well as key projects for the urban<br />
area in connection with the Life Sciences.<br />
18
Change language